文献速递神经MR

脑胶质瘤:动态对比增强与动态磁敏感对比MR图像的多中心标准化评估

Brain Gliomas: Multicenter Standardized Assessment of Dynamic Contrast-enhanced and Dynamic Susceptibility Contrast MR Images.
PubMed 文献 · Radiology · 2018-01-22

该前瞻性多中心研究在7个中心采用统一术前MR方案(含DCE与DSC序列)检查100例胶质瘤患者,评估标准化采集与分析方案的可行性及其按WHO 2016分类预测分级的准确性;方案在所有患者中耐受,94例成功获得灌注图,DCE参数vp与ve及DSC参数rCBV均显示高诊断准确性且两者差异无统计学意义(P > .05)。

要点

  • 标准化多中心DCE与DSC MR采集分析方案可行且重复性高。
  • DCE参数vp与ve对胶质瘤分级的AUC分别为0.847与0.853。
  • DSC参数rCBV的AUC为0.894,与DCE参数差异无统计学意义(P > .05)。

核心结论

  • 标准化的多中心DCE与DSC MR采集与分析方案可行且高度可重复,两种技术对胶质瘤分级均显示相当的高诊断准确性。

研究设计与样本

  • 前瞻性多中心研究,100例胶质瘤患者,在7个中心于3.0 T行统一术前MR方案(含DCE与DSC序列),以WHO 2016分类为分级参照。

关键影像表现/征象

  • 在Ktrans、vp、ve、初始浓度曲线下面积及rCBV图上由两名独立阅片者识别灌注热点。
  • 全部患者均耐受完整方案,94例成功获得灌注图。
  • DSC与DCE衍生指标的阅片者间重复性极好。

诊断标准与关键数值

  • DCE参数中vp与ve对胶质瘤分级的准确性最高,AUC分别为0.847与0.853。
  • DSC参数rCBV的AUC为0.894,与DCE参数差异无统计学意义(P > .05)。
  • 低级别胶质瘤中,异柠檬酸脱氢酶野生型肿瘤的vp与rCBV均可见中度升高,但差异无统计学意义(P > .05)。

临床应用与阅片要点

  • 多中心临床环境下可采用统一的DCE与DSC MR采集与分析方案进行胶质瘤术前评估。
  • 阅片时可在Ktrans、vp、ve、初始浓度曲线下面积及rCBV图上识别灌注热点以辅助分级。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To evaluate the feasibility of a standardized protocol for acquisition and analysis of dynamic contrast material-enhanced (DCE) and dynamic susceptibility contrast (DSC) magnetic resonance (MR) imaging in a multicenter clinical setting and to verify its accuracy in predicting glioma grade according to the new World Health Organization 2016 classification. Materials and Methods The local research ethics committees of all centers approved the study, and informed consent was obtained from patients. One hundred patients with glioma were prospectively examined at 3.0 T in seven centers that performed the same preoperative MR imaging protocol, including DCE and DSC sequences. Two independent readers identified the perfusion hotspots on maps of volume transfer constant (Ktrans), plasma (vp) and extravascular-extracellular space (ve) volumes, initial area under the concentration curve, and relative cerebral blood volume (rCBV). Differences in parameters between grades and molecular subtypes were assessed by using Kruskal-Wallis and Mann-Whitney U tests. Diagnostic accuracy was evaluated by using receiver operating characteristic curve analysis. Results The whole protocol was tolerated in all patients. Perfusion maps were successfully obtained in 94 patients. An excellent interreader reproducibility of DSC- and DCE-derived measures was found. Among DCE-derived parameters, vp and ve had the highest accuracy (are under the receiver operating characteristic curve [Az] = 0.847 and 0.853) for glioma grading. DSC-derived rCBV had the highest accuracy (Az = 0.894), but the difference was not statistically significant (P > .05). Among lower-grade gliomas, a moderate increase in both vp and rCBV was evident in isocitrate dehydrogenase wild-type tumors, although this was not significant (P > .05). Conclusion A standardized multicenter acquisition and analysis protocol of DCE and DSC MR imaging is feasible and highly reproducible. Both techniques showed a comparable, high diagnostic accuracy for grading gliomas. © RSNA, 2018 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Anzalone N, Castellano A, Cadioli M, et al. Brain Gliomas: Multicenter Standardized Assessment of Dynamic Contrast-enhanced and Dynamic Susceptibility Contrast MR Images. Radiology. 2018. PMID: 29361245. doi:10.1148/radiol.2017170362

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。